Tag results:

Publication

Postpartum Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Lean Mouse Model of Gestational Diabetes Mellitus

[Scientific Reports] This preclinical study evaluated the metabolic dysfunction-associated steatotic liver disease development in a lean gestational diabetes mellitus mouse model with impaired insulin secretion capacity.

miR-31-5p Suppresses Myocardial Hypertrophy by Targeting Nfatc2ip

[Journal of Cellular and Molecular Medicine] The authors studied young rats to establish abdominal aorta coarctation (AAC) for four weeks. AAC-induced rats showed enlarged myocardiocytes and alterations in microRNAs, especially downregulated miR-31-5p. miR-31-5p targeted the 3′UTR of Nfatc2ip and inhibited myocardial hypertrophy in vitro and in vivo.

KCNK1 Promotes Proliferation and Metastasis of Breast Cancer Cells by Activating Lactate Dehydrogenase a (LDHA) and Up-Regulating H3K18 Lactylation

[PLOS Biology] Investigators reported that potassium two pore domain channel subfamily K member 1 (KCNK1) was significantly up-regulated in human breast cancer and was correlated with poor prognosis in breast cancer patients. KCNK1 promoted breast cancer proliferation, invasion, and metastasis in vitro and in vivo.

Engineered Extracellular Vesicles for Targeted Reprogramming of Cancer-Associated Fibroblasts to Potentiate Therapy of Pancreatic Cancer

[Signal Transduction and Targeted Therapy] Scientists developed engineered extracellular vesicles for the targeted reprogramming of cancer-associated fibroblasts and modulating the tumor microenvironment in pancreatic cancer.

(-)-Epigallocatechin 3-Gallate Protects Pancreatic β-Cell against Excessive Autophagy-Induced Injury through Promoting FTO Degradation

[Autophagy] The authors explored the potential protective effects of (-)-epigallocatechin 3-gallate on β-cell-specific NR3C1 overexpression mice in vivo and NR3C1-enhanced β cells in vitro.

Successful Use of Anti-CD19 CAR T Cells in Severe Treatment-Refractory Stiff-Person Syndrome

[Proceedings of The National Academy of Sciences of The United States of America] CAR T cell infusion resulted in reduced leg stiffness, drastic improvement in gait, walking speed increase over 100%, and daily walking distance improvement from less than 50 m to over 6 km within 3 months.

Popular